A study has found that a combination of netarsudil and latanoprost is a useful fixed dose option for treating open-angle glaucoma and reducing intraocular pressure (IOP). This combination therapy was shown to be effective in managing the condition. Cookies are used on the website for analytics, advertising, and site improvement, with users agreeing to their…
A webinar on April 16 at 1pm ET will discuss how healthcare organizations and health tech companies can collaborate to improve interoperability through eConsent, moderated by Aneesh Chopra. The panel, including representatives from DocuSign and Velatura, will focus on streamlining patient consent for sharing protected health information (PHI), complying with regulations, and improving care coordination….
The Cabinet has approved new legislative amendments to expand pharmacists’ responsibilities, including the ability to prescribe. The Expert Taskforce on Pharmacy in Ireland has been reviewing the role of pharmacists in primary care and has made recommendations for changes. Health Minister Stephen Donnelly has secured approval for an amendment to the Health (Miscellaneous Provisions) Bill…
More than $4.3 billion in opioid settlement funds have been distributed to city, county, and state officials, with more to come. However, some places are using the money to replace existing funding instead of adding necessary treatment and prevention services. Critics argue that this approach is not addressing the ongoing addiction crisis effectively. A debate…
The 2024 ADA Standards of Care recommend continuous glucose monitoring (CGM) for all people with type 1 diabetes. CGM, along with certain insulins, can help people recognize, prevent, and treat hypoglycemia. Joanne Rinker, a board-certified advanced diabetes manager, highlighted these changes at a conference. Providers are encouraged to offer CGM to all adults on insulin,…
Intra-Cellular Therapies announced positive results from a Phase 3 clinical trial for its antipsychotic medicine Caplyta in treating major depressive disorder. The study showed a significant reduction in depressive symptoms compared to a placebo on the MADRS scale. The drug also demonstrated benefits on a patient-reported measure of depression severity. Common side effects included dry…
NHS England has initially decided to stop accepting new sign-ups to the NHS Practitioner Health program, which provides mental health and addiction services to healthcare professionals. This decision sparked dismay and disbelief among doctors, prompting NHS England to reverse the decision. The organization stated that they are reviewing staff support options for mental health across…
New guidelines called TRIPOD+AI have been introduced to update the reporting standards for clinical prediction models, reflecting the increasing use of artificial intelligence (AI) in medical decision-making tools. These guidelines aim to improve transparency and accuracy in studies developing and evaluating AI prediction models, emphasizing trustworthiness, fairness, and the importance of reporting. Led by researchers…
A lawsuit filed in Florida claims that large insurance call centers enrolled people in Affordable Care Act plans or switched their coverage without permission in a scheme to make money. The call centers paid to obtain names of individuals who responded to misleading advertisements promising government subsidies. The sales agents then used this information to…
A study presented at the annual meeting of the American Society for Laser Medicine and Surgery found that patients who experienced complications following dermatologic cosmetic procedures had high rates of mental health issues. Survey results from 100 individuals showed that rates of anxiety disorder, depression, body dysmorphic disorder, and PTSD were significantly higher after complications….
